Aclairo Pharmaceutical Development Group Information
Summary
Aclairo Pharmaceutical Development Group is a private company that has been in the industry for 22 years. The company currently specializes in the Biotechnology area. The position of the President & CEO is occupied by Hilary Sheevers. Its headquarters is located at Vienna, Virginia, USA. The number of employees ranges from 25 to 100. The annual revenue of Aclairo Pharmaceutical Development Group varies between 5.0M and 25M. To connect with Aclairo Pharmaceutical Development Group employee register on SignalHire.
Organization Website | Aclairo.com |
Industries | |
Headquarters Location | 45600 Terminal Dr, Sterling, Virginia, 20166 US |
Employees Size | 10-50 employees |
Specialties | Regulatory Services, Preclinical Project Management, Scientific Writing, Preclinical ADME, IND Preparation, CTD/eCTD Maintenance, Gap Analyses, Toxicology, Pharmacology, NDA/MAA preparation, cell and gene therapy, small molecule, large molecule, Nonclinical consulting, TK Analysis and reports |
SIC Code | 8000 |
DMA Code | Washington Metropolitan Area |
Founded | 2004 |
Estimated Annual Revenue | $5.0M - 25M |
Operating Status | Subsidiary |
Employees Turnover 4 quarter 2025
Length of Employment
Employee tenure at Aclairo Pharmaceutical Development Group shows a diverse range of experience levels:
8% for 1–2 years8% for 3–4 years15% for 5–7 years15% for 8–10 years54% have over 11 years of service at Aclairo Pharmaceutical Development Group
Similar Companies
FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
